Effect of Acute Hypoxia on RIght VEntRicular Function in Asthma.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorMona Lichtblau

About this trial

More and more people are engaging in sports in the mountains, including individuals with heart or lung diseases. At the same time, such diseases are becoming more common in Switzerland. At high altitude, less oxygen is available, which places stress on the body-particularly on the heart, which has to pump blood through the lungs. How the heart, especially the right ventricle, in people with asthma responds to this stress is still not well understood.

Therefore, this study investigates how the heart responds to simulated altitudes of 2,500 m and 4,000 m, both at rest and during light physical activity in patients with asthma. The primary objective is to assess how right ventricular function changes under conditions of reduced oxygen availability.

In addition, vital signs, changes in blood gases, oxygen levels in blood and tissue and shortness of breath are assessed. The "altitude" is simulated using a special gas mixture that participants inhale. Participants undergo three altitude conditions (490, 2,500, and 4,000 m above sea level). The order of the altitude conditions is assigned at random.

The aim is to better understand how the right ventricle and other parameters respond to low-oxygen conditions and how affected patients can be better supported in the future.

Eligibility criteria

Qualifiers

Signed informed consent

Diagnosed and well controlled asthma bronchiale

18-80 years (age group young: 18-39.99 years / age group older: 40-80 years)

All sex and genders

Disqualifiers

<18, >80 years old

Any other diagnosed cardiopulmonary condition including past HAPE

Other clinically significant severe concomitant disease states (e.g. renal, hepatic dysfunction, etc.)

Inability to follow the procedures of the study due to language problems, psychological neurological disorders or orthopaedic disorders

Trial design

Treatments tested in this trial

  • Normobaric Hypoxia

Treatment groups

18 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Sponsors and collaborators

Mona Lichtblau

Lead sponsor

University of Zurich

Sponsor institution